Management of Hyponatremia

Correction Limits and Monitoring

• The American Academy of Neurosurgery recommends that the total correction of sodium should not exceed 8 mmol/L in 24 hours, with a target correction of 6 mmol/L over 6 hours or until severe symptoms improve 1
• Sodium levels should be checked every 2 hours initially for patients with severe symptoms, and every 4 hours for those with mild symptoms 1
• The formula for sodium deficit calculation is: Desired increase in Na (mEq) × (0.5 × ideal body weight), as recommended by the Neurosurgery society and the American Academy of Neurosurgery 1
• Maximum correction of sodium levels should not exceed 8-10 mmol/L in 24 hours to prevent osmotic demyelination syndrome (ODS), as recommended by the American Association for the Study of Liver Diseases and the American Academy of Neurology 2, 3

Special Considerations

• Neurosurgical patients may need treatment even with sodium levels of 131-135 mmol/L, especially with subarachnoid hemorrhage 1
• Chronic hyponatremia should not be rapidly corrected due to the risk of osmotic demyelination syndrome (ODS) 1
• Patients with subarachnoid hemorrhage, malnutrition, alcoholism, and advanced liver disease are at higher risk for ODS and should be closely monitored, as stated by the European Association for the Study of the Liver and the American Academy of Neurosurgery 2, 1
• Children are at particularly high risk of developing symptomatic hyponatremia because of their larger brain/skull size ratio, as noted by the American Academy of Pediatrics 4

Classification and Treatment of Hyponatremia

• Hyponatremia can be classified into three types: hypovolemic, euvolemic, and hypervolemic, each with distinct characteristics and causes, as stated by the American Heart Association, the National Kidney Foundation, and the European Association for the Study of the Liver 2
• The following table summarizes the characteristics and initial treatment of different volume statuses:

• The primary treatment for hypovolemic hyponatremia involves administration of isotonic (0.9%) saline, as recommended by the American Association for the Study of Liver Diseases 6
• In cirrhosis, spironolactone (starting dose 100 mg, increased to 400 mg) alone or in combination with furosemide (starting dose 40 mg, increased to 160 mg) may be used, as suggested by the European Association for the Study of the Liver 2
• For patients with severe symptoms, administration of 3% hypertonic saline is recommended, with a target correction rate of up to 5 mmol/L in the first hour, according to the American Association for the Study of Liver Diseases 3
• Vaptans (vasopressin receptor antagonists) may be considered in select cases, but with caution in patients with cirrhosis due to increased mortality risk, as noted by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases 2, 6, 3

Treatment Outcomes and Complications

• Undertreating severe symptomatic hyponatremia can lead to delays in treating severe symptoms, resulting in increased mortality 1
• Untreated or improperly managed hyponatremia is associated with increased mortality in cirrhotic patients, decreased quality of life, and a higher risk of complications including hepatorenal syndrome 7
• Electrolyte imbalance correction is crucial to prevent complications such as ODS and to improve patient outcomes, as recommended by various medical societies including the American Society of Anesthesiologists and the American Diabetes Association 8, 9
• Fluid restriction of 1-1.5 L/day is the cornerstone of first-line treatment for SIADH, with pharmacological options including tolvaptan reserved for cases that fail to respond to conservative measures 1, 10
• High solute intake, including high protein diet and salt tablets (NaCl 100 mEq PO TID), can be used if there is no response to fluid restriction 1